Literature DB >> 12473427

Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model.

Sharon Manne1, Arnold Markowitz, Sidney Winawer, Jose Guillem, Neal J Meropol, Daniel Haller, Lina Jandorf, William Rakowski, James Babb, Terry Duncan.   

Abstract

BACKGROUND: There is a need for research to identify factors influencing intentions to undergo colorectal cancer (CRC) screening among family members at risk for CRC. This study tested a mediational model primarily guided by Ronis' elaboration of the Health Belief Model in predicting intention to have colorectal cancer screening among siblings of individuals diagnosed with colorectal cancer prior to age 56 years.
METHODS: Data were collected from 534 siblings of individuals diagnosed with CRC. A baseline survey was administered by telephone. Measures included perceived susceptibility, CRC severity, physician and family support for CRC screening, cancer-specific distress, the closeness of the relationship with the affected sibling, and future intention to have a colonoscopy. Participant age, gender, and number of prior colonoscopies, as well as the stage of the affected patient's cancer and time from the patient's diagnosis to the interview, were controlled for in the analyses.
RESULTS: The proposed model was not a good fit to the data. A respecified model was fit to the data. In this model, physician support, family support, and sibling closeness were significantly associated with both perceived benefits and barriers. Perceived severity was associated with barriers. Benefits and barriers, as well as cancer-specific distress, were directly associated with colonoscopy intentions. Results were consistent with a mediational role for benefits and barriers in the associations of sibling closeness and with a mediational role for barriers in the association between perceived severity and colonoscopy intentions. Family and physician support impacted intentions both directly and indirectly through effects on benefits and barriers. Perceived risk was not associated with benefits, barriers, or colonoscopy intentions.
CONCLUSION: Intervention efforts to increase colonoscopy intentions may benefit from targeting family influences, particularly the affected proband in the family, as well as physician influence, cancer-related distress, perceived CRC severity, and perceived benefits and barriers to colonoscopy.

Entities:  

Mesh:

Year:  2003        PMID: 12473427     DOI: 10.1006/pmed.2002.1122

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  27 in total

Review 1.  Individual-level factors in colorectal cancer screening: a review of the literature on the relation of individual-level health behavior constructs and screening behavior.

Authors:  Marc T Kiviniemi; Alyssa Bennett; Marie Zaiter; James R Marshall
Journal:  Psychooncology       Date:  2010-10-27       Impact factor: 3.894

2.  Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators.

Authors:  Maida J Sewitch; Pascal Burtin; Martin Dawes; Mark Yaffe; Linda Snell; Mark Roper; Patrizia Zanelli; Alan Pavilanis
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

3.  Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis.

Authors:  Amy E Bonomi; Denise M Boudreau; Paul A Fishman; Richard T Meenan; Dennis A Revicki
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

Review 4.  Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

5.  Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer.

Authors:  Sharon L Manne; Elliot J Coups; Gary Winkel; Arnold Markowitz; Neal J Meropol; Samuel M Lesko; Paul B Jacobsen; Daniel Haller; Lina Jandorf; Susan K Peterson
Journal:  Health Educ Res       Date:  2009-08-04

6.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

7.  Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.

Authors:  Maida J Sewitch; Mengzhu Jiang; Roland Grad; Mark Yaffe; Alan Pavilanis; Lawrence Joseph; Alan N Barkun; Mark Roper
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

8.  Factors Associated with Colorectal Cancer Screening among Younger African American Men: A Systematic Review.

Authors:  Charles R Rogers; Patricia Goodson; Margaret J Foster
Journal:  J Health Dispar Res Pract       Date:  2015

9.  An examination of the psychosocial factors influencing colorectal cancer patients' communication of colorectal cancer patient risk with their siblings.

Authors:  Catalina Lawsin; Katherine Duhamel; Steven Itzkowitz; Karen Brown; Helen Lim; Lina Jandorf
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

10.  Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France.

Authors:  Isabelle Ingrand; Sarah Dujoncquoy; Virginie Migeot; Véronique Ghadi; Michel Beauchant; Pierre Ingrand
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.